Graviton BioScience Corp — Form D
Graviton BioScience Corp of New York, NY, a company, filed a Form D exempt-offering notice with the SEC on 2024-02-14. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-02-14
- Form: D
- Accession: 0001231919-24-000017
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 1
- Date of first sale: 2024-01-31
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-505280
Issuer
- Name: Graviton BioScience Corp
- CIK: 0001847048
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 125 West End Ave, New York, NY, 10023
- Phone: 332-400-0444
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| James D Boylan | Director | New York, NY |
| BIHUA CHEN | Director | Boston, MA |
| Jeremy D Levin | Director | New York, NY |
| David D MacMillan | Director | New York, NY |
| Ran D Nussbaum | Director | New York, NY |
| Stelios D Papadopoulos | Director | New York, NY |
| Samuel D Waksal | Director | New York, NY |
| Samuel D Waksal | Executive Officer | New York, NY |
| Samuel D Waksal | Promoter | New York, NY |
| Bihua D Chen | Director | Boston, MA |
| Philip Barach | Director | Portland, ME |
| Steven Gordon | Director | New York, NY |
| Steven Gordon | Executive Officer | New York, NY |
| Samuel Waksal | Director | New York, NY |
| Richard Giroux | Director | New York, NY |
Other filings by this issuer (3)
More